There was a statistically significant higher rate of EREG expression in dead NSCLC patients (p-value = 0.042), while a trend toward more ADH1C expression was discovered in surviving patients (Figures 10D1, E1). The gene discussed is ADH1C; the disease is non-small cell lung carcinoma.